4th Quarter - Report

WINNING STRATEGIES WASHINGTON for KALEO

Firm
Client
Income
$30,000
Expenses
—

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Defense DEF

Medical countermeasures research and development

LobbyistCovered position, as disclosed
MICHAEL A MEROLA Deputy CoS, Sen. Torricelli
CHARLA PENN LA, Rep. Pascrell; SA/LC/LA, Rep. Boyd
CHELSEY PENROD HICKMAN CoS, LD, Rep. Kay Granger; Deputy LD, LA Sen. Larry Craig
ROBERT ZUCKER LD, Rep. Rothman; LA, Rep. Evans (IL); Sen. Lautenberg

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Health Issues HCR

Legislation related to prescription drug prices; access to epinephrine in schools and other community settings

LobbyistCovered position, as disclosed
MICHAEL A MEROLA Deputy CoS, Sen. Torricelli
CHARLA PENN LA, Rep. Pascrell; SA/LC/LA, Rep. Boyd
CHELSEY PENROD HICKMAN CoS, LD, Rep. Kay Granger; Deputy LD, LA Sen. Larry Craig
ROBERT ZUCKER LD, Rep. Rothman; LA,Rep. Evans (IL); Sen. Lautenberg

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Pharmacy PHA

Pharmaceutical drug development, including epinephrine for anaphylaxis; drug access and affordability issues

LobbyistCovered position, as disclosed
MICHAEL A MEROLA Deputy CoS, Sen. Torricelli
CHARLA PENN LA, Rep. Pascrell; SA/LC/LA, Rep. Boyd
CHELSEY PENROD HICKMAN CoS, LD, Rep. Kay Granger; Deputy LD, LA Sen. Larry Craig
ROBERT ZUCKER LD, Rep. Rothman; LA,Rep. Evans (IL); Sen. Lautenberg

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.